Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Muscle & Nerve
|
February 8, 2025
Comparison of Two Questionnaires for Sleep-Related Symptoms in Pediatric and Adult Patients With Myotonic Dystrophy Type 1
Eleonora Silvana D'Ambrosio, Megan Rose, Shannon Chagat, et al.
Pediatrics
|
February 11, 2026
ALT/CK Ratio as an Early Marker of Liver Injury After Gene Therapy in Duchenne Muscular Dystrophy
Eleni Drakou, Catrice Needum, Kylee Konst, et al.
Journal of Neuromuscular Diseases
|
February 20, 2025
Gross motor delays in infants and young boys with Duchenne muscular dystrophy
Linda P Lowes, Natalie F Reash, Megan A Iammarino, et al.
Muscle & Nerve
|
January 2, 2025
Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single-Center Experience
Can Ebru Bekircan-Kurt, Sharmada Subramanian, Shannon Chagat, et al.
Neuromuscular Disorders : NMD
|
December 24, 2023
Continued safety and long-term effectiveness of onasemnogene abeparvovec in Ohio
Megan A Waldrop, Shannon Chagat, Michael Storey, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Muscle & Nerve
|
February 8, 2025
Comparison of Two Questionnaires for Sleep-Related Symptoms in Pediatric and Adult Patients With Myotonic Dystrophy Type 1
Eleonora Silvana D'Ambrosio, Megan Rose, Shannon Chagat, et al.
Pediatrics
|
February 11, 2026
ALT/CK Ratio as an Early Marker of Liver Injury After Gene Therapy in Duchenne Muscular Dystrophy
Eleni Drakou, Catrice Needum, Kylee Konst, et al.
Journal of Neuromuscular Diseases
|
February 20, 2025
Gross motor delays in infants and young boys with Duchenne muscular dystrophy
Linda P Lowes, Natalie F Reash, Megan A Iammarino, et al.
Muscle & Nerve
|
January 2, 2025
Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single-Center Experience
Can Ebru Bekircan-Kurt, Sharmada Subramanian, Shannon Chagat, et al.
Neuromuscular Disorders : NMD
|
December 24, 2023
Continued safety and long-term effectiveness of onasemnogene abeparvovec in Ohio
Megan A Waldrop, Shannon Chagat, Michael Storey, et al.
Page
of 1